KORU Medical SystemsvsMerck & Company

KRMD and MRK stock compared: price, dividend, valuation and results, from SEC filings.

KRMD

KORU Medical Systems, Inc.

$3.69

Value $160M

-0.27%
KRMD's page

MRK

Merck & Company, Inc.

$144.46

Value $357B

-2.23%
MRK's page

KORU Medical Systems (KRMD) has a market value of $160M and Merck & Company (MRK) $357B. Over the last year, with dividends, KRMD moved -14.6% and MRK +60.0%. Dividend yield: KRMD none, MRK 2.35%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    KRMD$160M

    MRK$357B

    MRK is 2,232 times KRMD

  • Revenue, 12 months

    KRMD$46M

    MRK$67.4B

    MRK is 1,456 times KRMD

  • Net income, 12 months

    KRMD-$823.4K

    MRK$2.5B

  • Operating margin

    KRMD-1.3%

    MRK–

  • ROIC

    KRMD-2.7%

    MRK3.9%

    6.5 points apart

  • P/E

    KRMD–

    MRK145.6

  • Dividend yield

    KRMD0.0%

    MRK2.4%

    2.4 points apart

  • 5-year return

    KRMD+4.2%

    MRK+101.1%

    96.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

KRMD+4.2%

MRK+101.1%

5010015020020222023202420252026
Returns by period
PeriodKRMDWith dividendsMRKWith dividends
1 year since November 14, 2025-14.6%Price -14.6%+60.0%Price +55.5%
3 years since November 16, 2023+67.7%+18.8% a yearPrice +67.7%+55.2%+15.8% a yearPrice +41.6%
5 years since November 15, 2021+4.2%+0.8% a yearPrice +4.2%+101.1%+15.0% a yearPrice +72.6%
10 years since November 16, 2016+770.3%+24.2% a yearPrice +770.3%+228.0%+12.6% a yearPrice +141.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

KRMDKORU Medical SystemsMRKMerck & Company

Valuation

KRMDMRK
Valuation
Price$3.69$144.46
Market value$160M$357B
Enterprise value (EV)$153M$401B
P/E–145.6
P/E, 5-year median–14.8
P/B8.38.0
EV/EBIT–84.3
Free cash flow yield–4.1%

Results and growth

KRMDMRK
Results and growth
Revenue, 12 months$46M$67.4B
Net income, 12 months-$823.4K$2.5B
Free cash flow, 12 months-$387.4K$14.7B
Earnings per share, 12 months-$0.02$0.98
Revenue growth, year on year22.2%1.3%
Revenue growth a year, past+11.2%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

KRMDMRK
Margins and returns on capital
Gross margin63.6%71.8%
Operating margin-1.3%–
Net margin-1.8%3.6%
ROIC-2.7%3.9%
ROE-4.7%5.2%

Balance sheet

KRMDMRK
Balance sheet
Cash$7.4M$9.7B
Total debt$3.5M$53.8B
Net debt / EBITDA-32.25.7
Interest cover–2.4×

Dividends and buybacks

KRMDMRK
Dividends and buybacks
Dividend yield–2.4%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.4%
Shareholder yield–3.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: KRMD or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, KORU Medical Systems or Merck & Company?

By market value, Merck & Company ($357B) is about 2,231.5 times KORU Medical Systems ($160M), at today's prices.

How did KRMD and MRK stock do over the last 10 years?

Since November 16, 2016, KRMD's price moved +770.3% and MRK's +141.7%. With dividends: KRMD +770.3% (+24.2% a year), MRK +228.0% (+12.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, KRMD or MRK?

The dividend yield at today's price is none for KORU Medical Systems and 2.35% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

Which has the higher profit margins, KORU Medical Systems or Merck & Company?

Over the last twelve months, the net margin was -1.8% for KORU Medical Systems and 3.6% for Merck & Company, and the operating margin -1.3% and –. Revenue was $46M and $67.4B.

Which is the better investment, KORU Medical Systems or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.